The effectiveness of repurposed medications for treating COVID-19 remains a critical area of investigation. A new analysis found that higher-dose fluvoxamine (Luvox), an antidepressant with ...
Adults with prepandemic respiratory conditions, including asthma, bronchitis, and recurrent upper respiratory infections, are significantly more likely to develop long COVID after a mild-to-moderate ...
About The Study: In this randomized clinical trial of outpatients with mild to moderate COVID-19, treatment with montelukast did not reduce duration of COVID-19 symptoms. These findings do not support ...
Even a mild case of COVID-19 or the flu can impact the body long after the fever and cough fade, according to new Tulane University research that may help explain why some people struggle to feel ...
Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized controlled trial to show large and very large ...
A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results